查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1713193

全球虫媒病毒检测市场：产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Arbovirus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 180 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现

  • 虫媒病毒检测市场规模：10.944亿美元（2025年）
  • 预计市场价值：15.211亿美元（2032年）
  • 全球市场成长率：4.8%（2025年至2032年的复合年增长率）

虫媒病毒检测市场：报告范围

虫媒病毒检测在节肢动物传播病毒感染疾病，包括登革热、兹卡、基孔肯雅病毒、黄热病和西尼罗河病毒。这些疾病主要透过蚊子和蜱虫传播，对公共卫生构成重大挑战，尤其是在热带和亚热带地区。虫媒病毒检测市场包括用于医院、诊所、实验室和现场监测计画的分子诊断、血清学检测和照护现场。虫媒病毒感染疾病的流行，以及全球移民增加和气候变迁对媒介生态系统的影响，正在推动对先进诊断解决方案的需求。

市场成长动力

由于都市化、全球旅行以及有利于蚊子繁殖的环境变化等因素，全球虫媒病毒疾病的发生率激增，推动了全球虫媒病毒检测市场的发展。政府和非政府对感染疾病控制和公共卫生防范的资金增加正在刺激对疾病监测和诊断基础设施的投资。 PCR和次世代定序等分子诊断技术的进步使得快速且准确地检测虫媒病毒成为可能，有助于早期疗育和控制疫情。此外，流行地区对筛检计划的认识不断提高和实施也支持了市场的成长。

市场限制

儘管前景光明，但该市场仍面临挑战，包括低收入地区诊断工具获取管道有限、缺乏标准化检测通讯协定以及训练有素的实验室负责人短缺。在一些国家，分子检测成本高且保险覆盖范围有限，进一步限制了市场渗透。季节和趋势导致的需求波动也会影响製造商的生产计画和资源配置。此外，血清学检测方法的交叉反应，尤其是与黄病毒的交叉反应，可能导致误诊，影响检测可靠性和临床决策。

市场机会

虫媒病毒检测市场透过可携式照护现场诊断设备的创新提供了巨大的成长机会，这些设备可以快速提供结果并适合在疫情爆发期间现场使用。人工智慧和资料分析在流行病学建模中的整合将增强疾病预测和检测部署策略。加强公私合营进行研发以及出现能够同时检测多种虫媒病毒的多重检测将简化工作流程并降低诊断成本。扩大非旅行感染流行地区的检测和建立全球疾病监测网络将进一步为市场扩张铺平道路。

本报告研究了全球虫媒病毒检测市场，并对市场动态进行了详细分析，包括成长动力、趋势、机会和挑战。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值考虑

  • 监管格局
  • 测试类型采用分析
  • 技术进步
  • 疾病流行病学
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章全球虫媒病毒检测市场展望

  • 主要亮点
    • 市场规模及与前一年同期比较
    • 绝对的商机
  • 市场规模分析与预测
    • 市场规模表现分析（2019-2024）
    • 当前市场规模分析与预测（2025-2032）
  • 全球虫媒病毒检测市场展望：检测类型
    • 简介/主要发现
    • 按测试类型分類的市场规模绩效分析（2019-2024）
    • 按测试类型分類的当前市场规模分析和预测（2025-2032）
      • 血清学检测
      • 分子诊断检测
      • 其他的
    • 市场吸引力分析：测试类型
  • 全球虫媒病毒检测市场展望：病毒类型
    • 简介/主要发现
    • 按病毒类型分類的市场规模表现分析（2019-2024 年）
    • 目前市场规模分析及病毒类型预测（2025-2032）
      • 登革热病毒
      • 兹卡病毒
      • 基孔肯雅病毒
      • 黄热病毒
      • 西尼罗病毒
      • 日本脑炎病毒
      • 其他的
    • 市场吸引力分析：病毒类型
  • 全球虫媒病毒检测市场展望：最终用户
    • 简介/主要发现
    • 按最终用户分類的市场规模分析（2019-2024）
    • 目前市场规模分析及最终用户预测（2025-2032）
      • 医院和诊所
      • 诊断实验室
      • 研究中心
      • 公共卫生机构
      • 学术机构
    • 市场吸引力分析：最终用户

5. 全球虫媒病毒检测市场（按地区）展望

  • 主要亮点
  • 市场规模绩效分析：按地区（2019-2024）
  • 目前市场规模分析及各地区预测（2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

6. 北美虫媒病毒检测市场展望

7. 欧洲虫媒病毒检测市场展望

8. 东亚虫媒病毒检测市场展望

9. 南亚和大洋洲虫媒病毒检测市场展望

10. 拉丁美洲虫媒病毒检测市场展望

第十一章中东与非洲虫媒病毒检测市场展望

第十二章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthineers AG
    • Danaher Corporation (includes Cepheid, Beckman Coulter)
    • QIAGEN NV
    • bioMerieux SA
    • Meridian Bioscience, Inc.
    • NovaTec Immundiagnostica GmbH
    • InBios International, Inc.
    • Artron Laboratories Inc.
    • SD Biosensor, Inc.
    • CTK Biotech, Inc.
    • Euroimmun AG (a PerkinElmer company)
    • 其他的

第十三章 附录

简介目录
Product Code: PMRREP17032

Persistence Market Research has recently released a comprehensive report on the worldwide market for arbovirus testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global arbovirus testing market from 2025 to 2032.

Key Insights:

  • Arbovirus Testing Market Size (2025E): USD 1,094.4 Million
  • Projected Market Value (2032F): USD 1,521.1 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.8%

Arbovirus Testing Market - Report Scope:

Arbovirus testing plays a vital role in the diagnosis and surveillance of arthropod-borne viral infections such as dengue, Zika, chikungunya, yellow fever, and West Nile virus. These diseases are primarily transmitted by mosquitoes and ticks, posing significant public health challenges, particularly in tropical and subtropical regions. The arbovirus testing market comprises molecular diagnostics, serological tests, and point-of-care assays, used in hospitals, clinics, laboratories, and field surveillance programs. The increasing prevalence of arboviral outbreaks, coupled with rising global mobility and climate change effects on vector ecology, is driving demand for advanced diagnostic solutions.

Market Growth Drivers:

The global arbovirus testing market is propelled by the escalating incidence of arboviral diseases worldwide, driven by factors such as urbanization, global travel, and environmental changes that favor mosquito breeding. Rising government and non-governmental funding for infectious disease control and public health preparedness has spurred investments in disease surveillance and diagnostics infrastructure. Advancements in molecular diagnostic technologies, including PCR and next-generation sequencing, have enabled faster and more accurate detection of arboviruses, facilitating early intervention and outbreak containment. In addition, growing awareness and implementation of screening programs in endemic regions support market growth.

Market Restraints:

Despite the promising outlook, the market faces challenges including limited accessibility of diagnostic tools in low-income regions, lack of standardized testing protocols, and shortage of trained laboratory personnel. High costs associated with molecular tests and limited insurance coverage in some countries further restrict market penetration. Seasonal and outbreak-driven demand variability also affects production planning and resource allocation for manufacturers. Moreover, cross-reactivity in serological testing methods, particularly among flaviviruses, may lead to misdiagnosis, impacting test reliability and clinical decision-making.

Market Opportunities:

The arbovirus testing market presents substantial growth opportunities through innovations in portable, point-of-care diagnostic devices, which offer rapid results and are suitable for field use during outbreaks. Integration of artificial intelligence and data analytics in epidemiological modeling enhances disease forecasting and test deployment strategies. Increasing public-private partnerships for R&D and the emergence of multiplex assays capable of simultaneously detecting multiple arboviruses can streamline workflows and reduce diagnostic costs. Expansion of testing in non-endemic regions due to travel-related transmission and the establishment of global disease surveillance networks further open avenues for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the arbovirus testing market globally?
  • Which testing technologies and platforms are gaining traction in endemic and non-endemic regions?
  • How are innovations in molecular diagnostics influencing the arbovirus testing landscape?
  • Who are the key players in the arbovirus testing market, and what strategies are they employing to remain competitive?
  • What are the emerging trends and future prospects in the global arbovirus testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global arbovirus testing market, including Abbott Laboratories, Thermo Fisher Scientific Inc., bioMerieux SA, and Bio-Rad Laboratories, Inc., are focusing on technology development, strategic collaborations, and geographical expansion to enhance their market presence. These companies are investing in advanced diagnostic platforms and launching rapid, multiplex, and high-throughput testing kits to address increasing demand for accurate and timely diagnostics. Partnerships with public health agencies and academic institutions support surveillance initiatives and product innovation. Continuous focus on regulatory approvals, training programs, and awareness campaigns is aiding in expanding market access, particularly in resource-limited settings.

Key Companies Profiled:

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • Danaher Corporation (includes Cepheid, Beckman Coulter)
  • QIAGEN N.V.
  • bioMerieux SA
  • Meridian Bioscience, Inc.
  • NovaTec Immundiagnostica GmbH
  • InBios International, Inc.
  • Artron Laboratories Inc.
  • SD Biosensor, Inc.
  • CTK Biotech, Inc.
  • Euroimmun AG (a PerkinElmer company)
  • Others

Market Segmentation

By Test Type

  • Serological Tests
  • Molecular Diagnostic Tests
  • Others

By Virus Type

  • Dengue Virus
  • Zika Virus
  • Chikungunya Virus
  • Yellow Fever Virus
  • West Nile Virus
  • Japanese Encephalitis Virus
  • Others

By End-user

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Centers
  • Public Health Agencies
  • Academic Institutions

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Test Type Adoption Analysis
  • 3.3. Technological Advancements
  • 3.4. Disease Epidemiology
  • 3.5. Value Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global Arbovirus Testing Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Arbovirus Testing Market Outlook: Test Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
      • 4.3.3.1. Serological Tests
      • 4.3.3.2. Molecular Diagnostic Tests
      • 4.3.3.3. Others
    • 4.3.4. Market Attractiveness Analysis: Test Type
  • 4.4. Global Arbovirus Testing Market Outlook: Virus Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Virus Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
      • 4.4.3.1. Dengue Virus
      • 4.4.3.2. Zika Virus
      • 4.4.3.3. Chikungunya Virus
      • 4.4.3.4. Yellow Fever Virus
      • 4.4.3.5. West Nile Virus
      • 4.4.3.6. Japanese Encephalitis Virus
      • 4.4.3.7. Others
    • 4.4.4. Market Attractiveness Analysis: Virus Type
  • 4.5. Global Arbovirus Testing Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals & Clinics
      • 4.5.3.2. Diagnostic Laboratories
      • 4.5.3.3. Research Centers
      • 4.5.3.4. Public Health Agencies
      • 4.5.3.5. Academic Institutions
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Arbovirus Testing Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Arbovirus Testing Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Test Type
    • 6.2.3. By Virus Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 6.4.1. Serological Tests
    • 6.4.2. Molecular Diagnostic Tests
    • 6.4.3. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 6.5.1. Dengue Virus
    • 6.5.2. Zika Virus
    • 6.5.3. Chikungunya Virus
    • 6.5.4. Yellow Fever Virus
    • 6.5.5. West Nile Virus
    • 6.5.6. Japanese Encephalitis Virus
    • 6.5.7. Others
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostic Laboratories
    • 6.6.3. Research Centers
    • 6.6.4. Public Health Agencies
    • 6.6.5. Academic Institutions
  • 6.7. Market Attractiveness Analysis

7. Europe Arbovirus Testing Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Test Type
    • 7.2.3. By Virus Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 7.4.1. Serological Tests
    • 7.4.2. Molecular Diagnostic Tests
    • 7.4.3. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 7.5.1. Dengue Virus
    • 7.5.2. Zika Virus
    • 7.5.3. Chikungunya Virus
    • 7.5.4. Yellow Fever Virus
    • 7.5.5. West Nile Virus
    • 7.5.6. Japanese Encephalitis Virus
    • 7.5.7. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Research Centers
    • 7.6.4. Public Health Agencies
    • 7.6.5. Academic Institutions
  • 7.7. Market Attractiveness Analysis

8. East Asia Arbovirus Testing Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Test Type
    • 8.2.3. By Virus Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 8.4.1. Serological Tests
    • 8.4.2. Molecular Diagnostic Tests
    • 8.4.3. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 8.5.1. Dengue Virus
    • 8.5.2. Zika Virus
    • 8.5.3. Chikungunya Virus
    • 8.5.4. Yellow Fever Virus
    • 8.5.5. West Nile Virus
    • 8.5.6. Japanese Encephalitis Virus
    • 8.5.7. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Research Centers
    • 8.6.4. Public Health Agencies
    • 8.6.5. Academic Institutions
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Arbovirus Testing Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Test Type
    • 9.2.3. By Virus Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 9.4.1. Serological Tests
    • 9.4.2. Molecular Diagnostic Tests
    • 9.4.3. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 9.5.1. Dengue Virus
    • 9.5.2. Zika Virus
    • 9.5.3. Chikungunya Virus
    • 9.5.4. Yellow Fever Virus
    • 9.5.5. West Nile Virus
    • 9.5.6. Japanese Encephalitis Virus
    • 9.5.7. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Research Centers
    • 9.6.4. Public Health Agencies
    • 9.6.5. Academic Institutions
  • 9.7. Market Attractiveness Analysis

10. Latin America Arbovirus Testing Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Test Type
    • 10.2.3. By Virus Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 10.4.1. Serological Tests
    • 10.4.2. Molecular Diagnostic Tests
    • 10.4.3. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 10.5.1. Dengue Virus
    • 10.5.2. Zika Virus
    • 10.5.3. Chikungunya Virus
    • 10.5.4. Yellow Fever Virus
    • 10.5.5. West Nile Virus
    • 10.5.6. Japanese Encephalitis Virus
    • 10.5.7. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Research Centers
    • 10.6.4. Public Health Agencies
    • 10.6.5. Academic Institutions
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Arbovirus Testing Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Test Type
    • 11.2.3. By Virus Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 11.4.1. Serological Tests
    • 11.4.2. Molecular Diagnostic Tests
    • 11.4.3. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 11.5.1. Dengue Virus
    • 11.5.2. Zika Virus
    • 11.5.3. Chikungunya Virus
    • 11.5.4. Yellow Fever Virus
    • 11.5.5. West Nile Virus
    • 11.5.6. Japanese Encephalitis Virus
    • 11.5.7. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Research Centers
    • 11.6.4. Public Health Agencies
    • 11.6.5. Academic Institutions
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott Laboratories
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Test Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Roche Diagnostics
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. Bio-Rad Laboratories, Inc.
    • 12.3.5. Siemens Healthineers AG
    • 12.3.6. Danaher Corporation (includes Cepheid, Beckman Coulter)
    • 12.3.7. QIAGEN N.V.
    • 12.3.8. bioMerieux SA
    • 12.3.9. Meridian Bioscience, Inc.
    • 12.3.10. NovaTec Immundiagnostica GmbH
    • 12.3.11. InBios International, Inc.
    • 12.3.12. Artron Laboratories Inc.
    • 12.3.13. SD Biosensor, Inc.
    • 12.3.14. CTK Biotech, Inc.
    • 12.3.15. Euroimmun AG (a PerkinElmer company)
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations